Article Text

Download PDFPDF
Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle
  1. C. Hamers, DVM, PhD1,
  2. S. Galleau, DVM1,
  3. R. Chery1,
  4. M. Blanchet1,
  5. S. Goutebroze, DVM1,
  6. L. Besancon, MSc2,
  7. C. Cariou, PhD2,
  8. B. Werle-Lapostolle, PhD2 and
  9. P. Hudelet, DVM2
  1. 1 Merial SAS, Allée des Cyprès, 01150 Saint Vulbas, France
  2. 2 Merial SAS, 254 Rue M. Merieux, 69007 Lyon, France
  1. E-mail for correspondence:


The immunisation properties of an inactivated bluetongue virus serotype 8 (BTV-8) vaccine were evaluated in sheep and cattle. Five sheep were vaccinated with one dose of vaccine and five cattle were vaccinated with two doses 28 days apart. Six sheep and five cattle served as unvaccinated controls. All animals were subjected to a virulent BTV-8 challenge, and safety and antibody responses were monitored. All control animals developed disease and viraemia, while vaccinated animals were clinically protected and viraemia was completely prevented.

View Full Text

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.